Suppr超能文献

挑战性区域银屑病与优特克单抗生物疗法:疾病模式的影响

Challenging regional psoriasis and ustekinumab biotherapy: impact of the patterns of disease.

作者信息

Hermanns-Lê Trinh, Berardesca Enzo, Piérard Gérald E, Lesuisse Marianne, Piérard-Franchimont Claudine

机构信息

Department of Dermatopathology, University Hospital of Liège, 4000 Liège, Belgium.

出版信息

J Biomed Biotechnol. 2012;2012:413767. doi: 10.1155/2012/413767. Epub 2012 Aug 13.

Abstract

In some patients, psoriasis appears refractory to many treatments, particularly when the disease is confined to some specific body regions. In this respect, palmoplantar psoriasis and palmoplantar pustulosis are possibly related conditions in their immunopathomechanisms involving Il-12, IL-23, and Th17. Nail psoriasis and scalp psoriasis are two other particular psoriasis manifestations. Accordingly, ustekinumab was tested in a few of these patients. The present paper is limited to peer-reviewed case reports. Data were not supported by bioinstrumental assessments and controlled trials. Overall, they are indicative of potential efficacy. The cost-effectiveness and the risk-benefit assessments merit further investigations.

摘要

在一些患者中,银屑病似乎对许多治疗都具有抗性,尤其是当疾病局限于某些特定身体部位时。在这方面,掌跖银屑病和掌跖脓疱病在其涉及白细胞介素-12、白细胞介素-23和辅助性T细胞17的免疫发病机制中可能是相关病症。甲银屑病和头皮银屑病是另外两种特殊的银屑病表现形式。因此,在其中一些患者中对乌司奴单抗进行了测试。本文仅限于同行评审的病例报告。数据未得到生物仪器评估和对照试验的支持。总体而言,它们表明了潜在疗效。成本效益以及风险效益评估值得进一步研究。

相似文献

7
Interventions for nail psoriasis.指甲银屑病的干预措施。
Cochrane Database Syst Rev. 2013 Jan 31;2013(1):CD007633. doi: 10.1002/14651858.CD007633.pub2.
8
Ustekinumab: a new option in psoriasis therapy.优特克单抗:银屑病治疗的新选择。
Drugs. 2009 Jun 18;69(9):1141-52. doi: 10.2165/00003495-200969090-00001.
9
Concurrent treatment of chronic psoriasis and asthma with ustekinumab.乌司奴单抗治疗慢性银屑病合并哮喘。
J Dermatolog Treat. 2014 Feb;25(1):63-6. doi: 10.3109/09546634.2013.782095. Epub 2013 May 6.

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验